77 results
8-K
EX-10.1
AGRX
Agile Therapeutics Inc
23 Feb 24
Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds
4:30pm
8-K
EX-10.1
AGRX
Agile Therapeutics Inc
15 Feb 24
Net Revenue for Full Year 2023 Expected to be in the Range of $20 to $21 Million, an Increase of 84% to 93% Compared to Full Year 2022
4:45pm
S-1
EX-10.19
AGRX
Agile Therapeutics Inc
IPO registration
11 Dec 23
5:30pm
8-K
EX-10.1
AGRX
Agile Therapeutics Inc
4 Dec 23
Entry into a Material Definitive Agreement
8:00am
8-K
EX-10.1
mom0t6ffk
28 Sep 23
Entry into a Material Definitive Agreement
4:50pm
8-K/A
EX-10.1
s01na8bagbnug ntem6y
22 Aug 23
Departure of Directors or Certain Officers
8:30am
8-K
EX-10.2
gweyzvpn1sctyukc1mj
25 May 23
Agile Therapeutics Announces Pricing of $7.5 Million Public Offering
5:25pm
8-K
EX-10.1
e4b9zu
25 May 23
Agile Therapeutics Announces Pricing of $7.5 Million Public Offering
5:25pm
8-K
EX-10.1
dhbrrf 6ouq8fr
8 Jul 22
Agile Therapeutics Announces Pricing of
5:16pm